Further, PTH related-peptide (PTHrP) was shown to stimulate MCP-1 production by human bone marrow endothelial cells and osteoblasts resulting in increased osteoclast differentiation, prostate cancer cell proliferation and invasion in vitro6. Here, CCL2 is linked to prostate cancer.